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Abstract: Optical spectroscopy is increasingly used for cancer diagnostics. Tumor detection
feasibility in human kidney samples using mid- and near-infrared (NIR) spectroscopy, fluorescence
spectroscopy, and Raman spectroscopy has been reported (Artyushenko et al., Spectral fiber
sensors for cancer diagnostics in vitro. In Proceedings of the European Conference on Biomedical
Optics, Munich, Germany, 21–25 June 2015). In the present work, a simplification of the NIR
spectroscopic analysis for cancer diagnostics was studied. The conventional high-resolution NIR
spectroscopic method of kidney tumor diagnostics was replaced by a compact optical sensing device
constructively represented by a set of four light-emitting diodes (LEDs) at selected wavelengths and
one detecting photodiode. Two sensor prototypes were tested using 14 in vitro clinical samples of
7 different patients. Statistical data evaluation using principal component analysis (PCA) and partial
least-squares discriminant analysis (PLS-DA) confirmed the general applicability of the LED-based
sensing approach to kidney tumor detection. An additional validation of the results was performed
by means of sample permutation.
Keywords: tumor detection; kidney; fiber spectroscopy; optical sensor; near infrared; LED
1. Introduction
Cancer remains one of the main causes of mortality in Germany and worldwide [1]. To improve
the situation, a larger number of diagnostic analyses should be performed at different stages of cancer
medical handling, from preventive screening to treatment efficiency control. The implementation of
this strategy results in a high demand for easy-to-handle, cheap diagnostic devices.
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Malignant tumors are currently diagnosed using a number of methods, including non-invasive
techniques such as computer tomography, ultrasound and X-ray scanning, as well as invasive
procedures, including biopsies and diagnostic surgeries. Optical spectroscopy of the biological tissue,
also called spectral histopathology [2], is a relatively new and highly promising approach to the
non-invasive tumor diagnostics that has been actively investigated since the 1990s. Spectroscopic
measurements are typically inexpensive and rapid, which makes the approach very well suited for
diagnostic screening and routine prophylactic check-ups. As a promising method of tumor border
detection, optical sensing capable of providing hundreds of real-time analyses presents a viable
alternative to the traditional operative histopathology.
Neoplastic processes in a tissue inevitably result in its chemical and physical modification.
These changes can be captured by the spectroscopic measurement of various effects accompanying
the interaction of the tissue with an incident electromagnetic wave. Recent research results have
confirmed the feasibility of differentiation between malignant and healthy tissues using fluorimetry
and molecular spectroscopic techniques, that is, Raman scattering and infrared absorption or diffuse
reflection [3,4]. The development of diagnostic spectroscopy results in a better understanding of
chemical changes related to the pathological cell malfunction. In turn, in-depth knowledge of the
disease’s biochemistry stimulates the development of new diagnostic methods and approaches.
Diffuse reflectance near-infrared (NIR) spectroscopy is one of the most promising methods
for optical tissue analysis. Delivering a mixture of the scatter and absorbance information on the
light-to-tissue interaction enables the detection of both molecular (related to the functional group
vibrations) and morphological (due to the cell transformation) tissue changes, which makes it
particularly useful for the oncology diagnostics of tumors. Successful NIR analysis applications for
cancer detection in different tissues have been illustrated for the liver [5], the breast [6–9], the cervix [10],
oral cancer [11–13], the prostate [14,15], the lung [16], gastric cancer [17] and the esophagus [18].
The most popular wavelength region, from 900 to 1700 nm, covered by the majority of modern
NIR spectrometers includes intensive absorption bands of fat (lipids) and water known to be bright
biomarkers of some tumor types, for example, of breast cancer [19]. It is important that the NIR light
penetrates into the sample by up to 3 mm [20,21]; this depth cannot be reached by suitable spectroscopic
techniques in other wavelength regions. Another important advantage of the NIR diagnostics of tissue
tumors, compared to traditional methods, is the measurement flexibility due to the application of
fiber-based light guides and probes, which is necessary under clinical conditions (e.g., during a
surgery). The literature review revealed no data on kidney cancer diagnostics using fiber-based
NIR spectroscopy.
Recent works have shown that high-resolution NIR spectroscopy can be replaced by optical
sensing at a few specific wavelengths optimized for a particular application [22–25]. Technical
downgrade does not necessarily result in an accuracy loss. Inexpensive sensors may perform as well as
the respective full-scale spectroscopic techniques, or even better [20]. An inevitable loss of accuracy as
a result of a much lower sensor resolution is compensated for by excluding less- and non-informative
spectral regions (i.e., those containing irrelevant variance and noise) from consideration. The resulting
simplification of the data and models tends to improve the model’s robustness and hence the reliability
of a diagnosis.
In this study, a new tumor diagnostic sensor based on light-emitting diodes (LEDs) with emission
wavelengths in the region of 900–1500 nm was developed and tested. To the best of our knowledge, the
use of LED-based optical sensing for kidney cancer diagnostics has not yet been reported. Two sensor
prototypes were implemented and tested for kidney cancer diagnostics using seven pairs each of
tumor and normal in vitro clinical samples from different patients. Considering the novelty of the
presented approach, the main analytical task of this study was to establish the fundamental feasibility
of the LED-based optical diagnostics, that is, the sensor’s capability to capture cancer-related tissue
variances at a few selected wavelengths. The measurements on real kidney samples are expected to be
helpful for further sensor development.
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2. Materials and Methods
2.1. Samples
NIR spectral and sensor measurements were obtained from unstained cryo biopsies of normal
and tumor renal tissue in the Department of Urology at the Charité – Universitätsmedizin Berlin
(Germany). Seven pairs each of normal and tumor samples from different patients were investigated
after nephrectomy. The study complied with the Declaration of Helsinki. It was approved by the
Ethics Committee of Charité, approval number EA1/134/12.
The sample thicknesses were typically from 5 to 10 mm, in accordance with common
histopathological practice, as larger samples could not be shock-freezed as is required for clinical
investigation. Histological classification was performed in accordance with the World Health
Organization (WHO) criteria. The grading and staging were assigned following the rules of
Fuhrman [26] and the International Union Against Cancer (UICC) [27], respectively. To prepare
the tissue samples for analysis, they were thawed for 5 min at room temperature. It is common practice
to use ex vivo samples at the early research stages, as in the present proof-of-concept study. Although
the spectra of frozen/thawed biopsies can differ from real-life in vivo measurements, the possibility to
transfer the diagnostic model was shown in a previous work on Raman spectroscopy of cancer [28].
The first series of samples for the spectroscopic study (Series A) included three pairs of biopsies
corresponding to patient ID numbers 191, 194, and 198. Tumor samples in Series A belonged to grade 2,
which designates (by the Fuhrman nuclear grading system [26]) slightly irregular contours of cells with
diameters of about 15 µm and with nucleoli clearly observed under a microscope at a magnification of
over 200× (Figure 1).
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2, 1, 2, and 3. All the tumor samples in Series B belonged to the predominant clear cell renal cell 
carcinoma (cCRCC) sub-type. 
For the analysis, the tissue samples of renal biopsies were placed into separate 35 mm Petri 
dishes. To avoid any sample displacement during the measurement, the samples were glued to the 
bottom of the dish using a tissue-adhesive glue (TRUGLUE). A position-coding grid was drawn on 
the outer surface of the bottom of the dish (Figure 2). The measurements were performed in the center 
of each grid cell, which was entirely covered by the sample. An additional measurement of each 
sample was performed in a position corresponding to its geometrical center (the most remote from 
the edges). 
Figure 1. Biopsy microscope images of (a) normal and (b) kidney tumor tissue of patient 191 at
200× magnification.
The next series (Series B) was measured using an improved sensor prototype and included four
pairs of renal biopsies from patients 144, 149, 151 and 160; the respective tumor sample grades were
2, 1, 2, and 3. All the tumor samples in Series B belonged to the predominant clear cell renal cell
carcinoma (cCRCC) sub-type.
For the analysis, the tissue samples of renal biopsies were placed into separate 35 mm Petri dishes.
To avoid any sample displacement during the measurement, the samples were glued to the bottom of
the dish using a tissue-adhesive glue (TRUGLUE). A position-coding grid was drawn on the outer
surface of the bottom of the dish (Figure 2). The measurements were performed in the center of each
grid cell, which was entirely covered by the sample. An additional measurement of each sample was
performed in a position corresponding to its geometrical center (the most remote from the edges).
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Healthy and tumor tissues are marked as “N” and “T”, respectively. The grid period is 0.5 cm.
Individual data were designated by the sa ple type (T and N for tumor and normal samples,
respectively), the patient ID and the ordinal number of repeated spectral/sensor measurements.
An additional index such as C3 or B2 in Series B denoted the measurement position on the grid
(Figure 2); Cn was a special position in the sample center, irrelative to the grid. For example, N144_Cn_4
represents th fourth measurement in the center of the normal tissue sample for patient 144. The probe
re-positioning was performed before each repeated measurement at the same position on the sample.
2.2. NIR Spectroscopy
Series A samples were initially studied using NIR spectroscopy in the region of 899.2–1721.4 nm.
The NIR spectra were acquired using an Ocean Optics NIRQuest512 spectrometer (Ocean Optics, Inc.,
Dunedin, FL, USA) equipped with an InGaAs linear array det ctor with a resolution of about 3.1 nm
and with fiber-optic NIR reflecta ce prob by art phot nics GmbH (Berlin, Germany). An LS-1
tungsten halogen light source by Ocean Optics was employed as a light source. The measurements
were performed in the diffuse reflectance mode. The probe was fixed on a laboratory stand with
a special clamp allowing for vertical movement. The head of the probe was equipped with a cylindrical
stainless steel spacer to maintain a constant distance of 2 mm from the entrance of the optical fiber
to the studied sample and to prot ct the measurement point from am ient light. The measurements
were performed by bringing the tip of the spacer into immediate slight contact with the sample
surface. Spectralon white diffuse reflectance standard (labsphere, Inc., North Sutton, NH, USA)
was employed as a reference and was measured before each new biopsy sample. The spectra were
acquired as an average of five scans of 150 ms each using OceanView instrumental software by Ocean
Optics. The resulting dataset of Series A was a matrix formed by 41 spectra (in rows) recorded at 512
wavelengths. The data can be accessed at: https://tptcloud.com/data/view/3171.
2.3. Sensor Design and Data Acquisition
The main operating principle of any LED-based sensor is rapid sample scanning at several (usually
from two to seven) different wavelengths. The LEDs perform an alternating illumination of the sample,
and the remitted (back-scattered or reflected) light intensity is then detected by a photo diode.
The LEDs in both constructed sensor prototypes operated in a pulse mode. Square 10 µs pulses
at a frequency of 1000 Hz were used for the measurements. The pulses’ current intensity through
the LEDs was 1 A. The operating conditions were chosen to provide spectral stability of the LEDs.
Additionally, the pulse mode considerably slows down the degradation of LEDs, compared to
Sensors 2017, 17, 1914 5 of 17
continuous illumination. As the temperature noticeably affects the spectral properties of LEDs, this was
controlled using a built-in semiconductor sensor. Throughout the whole experiment, the sensor’s
internal temperature was maintained at 24 ± 1 ◦C (room temperature).
Four LEDs were used for the sensor construction with emission band maxima at 0.94 µm (sensor
channel U4), 1.17 µm (U3), 1.30 µm (U1) and 1.44 µm (U2). The spectra of the chosen LEDs (Jenoptik,
Jena, Germany) normalized to the emission intensity from 0 to 1 are presented in Figure 3.
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Figure 3. Normalized emission spectra of sensor light-emitting diodes (LEDs).
The sensors were equipped with 12 mm metal probes (Figure 4). In the experiment for Series A,
the tip of the vertically mounted probe contacted an investigated sample through a thin (about 0.5 mm)
quartz covering glass that protected the sample surface. In subsequent studies with an improved
sensor (Series B), the probe was equipped with its own sapphire glass window located at Brewster’s
angle (60.5◦) relative to the probe axis (Figure 4b). During the measurements, the samples were
touched by the probe’s sharp-angled tip only. In the latter case, therefore, the data was acquired at
a distance of 3–4 mm above the tissue surface. The probe modification before Series B measurements
were taken was implemented to eliminate the disadvantages observed for the initial sensor set-up:
a non-optimal (too short) fibers-to-sample distance and strong specular reflection by the covering
glass surface. Additionally, the built-in sapphire window protected the fibers and facilitated the
probe cleaning.
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Figure 4. Probe construction and measurement setup. (a) Experimental setup, and (b) probe
construction schematic: 1—light-emitting diodes (LEDs); 2—fiber cables; 3—stainless steel tube;
4—sapphire window (in Series A measurements, the probe tip had a right-angled shape and was
not protected by a glass window); and 5—photodiode detector. (Reproduced with permission from
authors [29]).
The voltage data from the sensors was registered and saved by our own software written in
LabView, version 14.0, by National Instruments (Austin, TX, USA).
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The data can be accessed at: https://tptcloud.com/data/view/3179 (Series A); https://tptcloud.
com/data/view/3180 (Series B).
2.4. Data Analysis Methods and Software
Multivariate data analysis was always prefaced by the mean centering of variables, that is, spectral
wavelengths and individual sensor channels. This was the only preprocessing applied to the sensor
data. The measurement N194_5 was eliminated from the Series A sensor data as it was an evident
outlier. Principal component analysis (PCA) [30] and partial least-squares discrimination analysis
(PLS-DA) [31] were employed for the analysis of both the sensor data and the NIR spectra.
In the case of full-spectral NIR measurements, second derivatives of the spectral data were
calculated using the algorithm by Savitzky-Golay [32] with a second-order polynomial and a smoothing
window width of 25 points.
The following numbers were used as a statistical measure of the discrimination method’s
performance: true positives (TP)—the number of correctly identified tumor samples; true negatives
(TN)—the number of correctly identified healthy tissue samples; false positives (FP)—the number
of healthy tissue samples incorrectly identified as a tumor; and false negatives (FN)—the number
of tumor samples incorrectly identified as healthy. The above numbers were used to derive percent
values for the sensitivity, %Sn = TP/(TP + FN), for the specificity, %Sp = TN/(FP + TN), and for the
accuracy, %Ac = (TP + TN)/(TP + FP + TN + FN) of the discrimination. The discriminant Q2 (DQ2)
value was additionally used for the model’s performance assessment (Equation (1)). The DQ2 is an
improved version of the conventional Q2 [33], which does not penalize the discrimination quality
if correct predictions (TP or TN) fall out the interval formed by the calibration range [34] (from 0 to 1
in our case):
DQ2 = 1− ∑i:yi=0 & yˆi>0(yi − yˆi)
2 +∑i:yi=1 & yˆi<1(yi − yˆi)2
∑i(yi − y)2
(1)
where yi and yˆi are the known and the predicted diagnosis, respectively, and y is the mean value of yi
in the vector y of responses.
Data analysis was performed in MATLAB R2008b (The MathWorks Inc., Natick, MA, USA);
PLS Toolbox, version 7.5 (Eigenvector Research Inc., Manson, WA, USA); and in the web-based
chemometrics software TPT-cloud (www.tptcloud.com) by Global Modelling (Aalen, Germany),
developed at Samara State Technical University (Samara, Russia).
2.5. Model Validation
Considering the limited availability of the biopsy material and the ethical aspects of its use,
conclusions about the general suitability of the NIR sensor analysis for cancer diagnostics and,
in particular, of four theoretically chosen LEDs are made on the basis of a very limited number
of investigated patients. The necessary pairs of healthy and tumor biopsies could only be obtained
from the whole kidney after nephrectomy, which constituted only about 30% of the total operation
material (in accordance with the internal statistics of Charité). This was an additional complication
limiting the sample availability.
In order to reduce the risk of overfitting caused by the limited experimental data volume,
a thorough validation of the discrimination models was required. Three validation methods were
applied to calculate the prediction statistics for each model: two types of cross-validation (CV)
and a random-subset validation (RSV). The CV methods were full leave-one-out (LOO) CV and
segmented CV procedures, for which the segments were formed by repeated measurements in
different sample positions. (In Series A, for which arbitrary measurement positions were used,
the segments were formed by six individual kidney samples.) In the third validation method,
a random subset of measurements containing about 15% of the whole data set (the number of
validation samples was chosen to be closest to this value) was excluded at the model building stage
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to be used for an independent prediction. To compensate for the random factor in the modeling
statistics, the procedure was repeated 1000 times, and cumulative numbers of TP, FP, TN, and FN
were used to calculate the %Sn, %Sp, and %Ac values. One-thousand iterations of the subset
selection–modeling–validation cycle assured the convergence of the reported statistics to constant
values independent of a particular subset. The optimal number of latent variables (LVs) to be retained
in the PLS-DA models was determined on the basis of both CV methods.
The resulting discrimination models for the sensor data were additionally subjected to
a permutation test (PT) [35]. The y-vector in the PT was randomized many times, before the following
model building and validation. The PT passed if none of the random data arrangements resulted in
better statistics than the original data. Typically, 50–100 PT trials were enough to reveal an overfitting.
The average number of misclassified measurements (NMC = FP + FN) throughout all the RSV cycles
was used as a PT merit function.
3. Results
3.1. NIR Spectroscopic Analysis and Sensor Simulation
The NIR spectra of the Series A samples are presented in Figure 5a. Generally, high spectral
background (reflectance percentage always remained below 50%, compared to the standard) was
quite typical for the biological tissue. This accounted for a relatively deep penetration of light into
the sample, where it could be absorbed or scattered and therefore lost for detection. The biopsy
size or tissue-type differences, as well as seemingly insignificant variations of the sample position
against the probe, may have resulted in a strong spectral variability. Thus, the reflectance percentage
detected at 900 nm mostly varied between 45% and 15%, and in one instance, it even fell below
5%. Different effects of the background (i.e., offset shift) and the overall spectrum intensity (i.e., the
distance between minimal and maximal values within a measurement) are clearly distinguishable.
A strong susceptibility of the spectral background to various factors, resulting in both additive and
multiplicative effects, is a well-known issue for the NIR measurements of highly scattering solids,
for example, powders. The tumor samples exhibited generally higher offsets and a better contrast
of the spectra, compared to the normal tissue, which could have been a consequence of their higher
light-scattering ability. Nonetheless, the raw spectra do not have any features enabling reliable cancer
identification with a naked eye.
The scatter-related variability can be mathematically eliminated using spectral derivatives.
A data transformation into second derivatives (Figure 5b) revealed a number of variables enabling
an unambiguous differentiation between healthy tissue and tumor tissue in the studied samples.
Positive peaks in the second-derivative spectra correspond to the negative reflectance peaks of the
components that could be hidden in the original data, although their derivative maxima could be
shifted because of the presence of interfering components. The most intensive positive peak in the
second-derivative data that is responsible for the diagnostics occurs at about 1400 nm. Two smaller
but highly relevant peaks are located at 1155 and 965 nm. The discriminative ability of negative
peaks in the middle part of the spectra should also not be neglected. In fact, the whole regions of
1100–1220 nm and 1350–1470 nm look very promising for cancer discrimination purposes. The former
region is associated with C–H vibrations in the lipids, and the latter is known to include intensive
second overtones of O–H bond vibrations in both lipids and water that may partially overlap [36]. It is
remarkable that even the region of low absorbance at about 1300 nm exhibits some discriminative
potential. In general, a visual inspection of the second-derivative spectra justified the theory-based
choice of the LED set for a sensor construction that perfectly hits the regions of interest.
The initial choice of LEDs was based on a priori knowledge of cancer biochemistry and optical
properties of the biological tissue. Two illumination wavelengths, that is, those near 1.0 µm (about
1000 nm) and at 1.45 µm (1450 nm), were chosen in order to fit the corresponding water absorption
bands’ maxima. One more LED with its emission maximum at 1.2 µm (1200 nm) was chosen to fit
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the lipid absorption band [37]. The ratio between water and lipids in the tissues was reported to be
important for cancer detection with NIR instruments [19,38]. The fourth LED at 1.3 µm (1300 nm)
was introduced into the system for scatter correction, as previous NIR measurements revealed high
variability in the background signal. The spectral region around this wavelength was not densely
“populated” in the NIR spectra.
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Figure 5. Analysis of near-infrared (NIR) spectra in Series A: (a) raw spectra, (b) second-derivative
spectra, and (c) partial least-squares discriminant analysis (PLS-DA) regression coefficients. Red and
green spectra in (a,b) correspond to tumor tissue and normal tissue, respectively.
The PLS-DA of the NIR spectra of Series A resulted in a full separation of the two sample classes
(Table 1 and Figure 6a), even for the raw spectral data, using a model with two LVs. The measurements
in different positions of the same biopsy tissue tended to form compact groups; therefore, all the
samples were clearly distinguishable from each other, independently of the diagnosis. The tumor
samples indicated higher diversity of measurements. The features of the model regression coefficient
(Figure 5c), that is, smooth negative peaks at about 980, 1200 and 1450 nm, provided an additional
statistical justification as to the importance of the chosen analytical regions for the LED sensor.
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Table 1. Partial least-squares discriminant analysis (PLS-DA) calibration and validation statistics of
tumor detection in Series A and B; two latent variables (LVs) were used in all models.
Data DQ2 TP FP TN FN %Sn %Sp %Ac
Calibration 1
An41 2 0.932 21 0 20 0 100.0 100.0 100.0
As41 3 0.917 21 0 20 0 100.0 100.0 100.0
As33 4 0.437 19 1 11 2 90.5 91.7 90.9
Bs170 5 0.181 62 5 70 33 65.3 93.3 77.6
Bs140 6 0.500 64 3 67 6 91.4 95.7 93.6
Full (leave-one-out) cross-validation
An41 0.920 21 0 20 0 100.0 100.0 100.0
As41 0.902 21 0 20 0 100.0 100.0 100.0
As33 0.358 18 1 11 3 85.7 91.7 87.9
Bs170 0.153 59 7 68 36 62.1 90.7 74.7
Bs140 0.478 63 3 67 7 90.0 95.7 92.9
Segmented cross-validation 7
An41 0.574 21 0 20 0 100.0 100.0 100.0
As41 0.488 14 0 20 7 66.7 100.0 82.9
As33 0.051 13 3 9 8 61.9 75.0 66.7
Bs170 0.068 51 7 68 44 53.7 90.7 70.0
Bs140 0.416 61 3 67 9 87.1 95.7 91.4
Random-subset validation 8
An41 0.916 100.0 100.0 100.0
As41 0.899 100.0 100.0 100.0
As33 0.345 82.4 86.1 83.8
Bs170 0.149 60.2 91.0 74.8
Bs140 0.480 89.9 95.7 92.8
1 Both training and validation of the model were performed using the full dataset. 2 Near-infrared (NIR) spectra
of Series A. 3 Simulated sensor data in Series A. 4 Sensor measurements in Series A. 5 Sensor measurements of
full data in Series B. 6 Sensor measurements of Series B without sample T151 or positions N144_Cn and T144_Cn.
7 Segments were formed by samples (Series A) or measurement positions (Series B). 8 Subset (15%) of the full data
at 1000 iterations.
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ID numbers are indicated): (a) near-infrared (NIR) spectra, and (b) simulated sensor data. 
In the next development step, the full-spectrum data were used for sensor simulations. To 
simulate the sensor data, the spectral variables in the analytical regions were averaged using the real 
Figure 6. Partial least-squares discriminant analysis (PLS-DA)-predicted (sample-based segmented
cross-validation (CV)) vs histologically observed tumor discrimination in Series A samples (patient ID
numbers are indicated): (a) near-infrared (NIR) spectra, and (b) simulated sensor data.
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In the next development step, the full-spectrum data were used for sensor simulations. To simulate
the sensor data, the spectral variables in the analytical regions were averaged using the real LED
spectra (Figure 3) as weights. This operation resulted in a 41 (samples) by 4 (channels) matrix that
was used to build another PLS-DA model for Series A. Despite the dramatic reduction of variables
(from 512 in the NIR spectra to 4) the simulated sensor kept its diagnostic capability. Moreover,
the predicted versus observed plots for the full and the reduced spectral data (Figure 6a,b) are very
similar. Measurement points in the simulated sensor model (Figure 6b) have a somewhat higher
scatter, in particular, for the tumor samples. As seven measurement points of the sample T191 fell
below the standard discrimination threshold of 0.5, it had to be shifted to 0.47 in order to achieve
full discrimination. Nevertheless, no misclassification was observed in either case, and the DQ2
values (Table 1) revealed no significant statistical difference between the full-spectrum and simulated
sensor models.
The class separation quality in the simulated data case can also be seen from the PLS-DA score plot
in Figure 7a. The PLS-DA scores for the real sensor measurements of the same sample set (Series A),
further discussed in Section 3.2, are presented in Figure 7b for comparison. Although the points are
more strongly scattered in this case, a nearly full separation of the tumor and normal tissue classes is
also observed.
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The analysis of the NIR spectroscopic data presented here was performed for the primary 
purpose of sensor development. Full-spectrum measurements enabled the simulation of a four-
channel sensor with theoretically chosen LEDs before its physical construction. The present 
discrimination modeling on the basis of poor experimental data including only a few patients was 
exploratory, but its results provide the necessary motivation for further sensor development. The 
practicable diagnostic model should be built at a later stage of the method development, using a large 
representative set of patients, and should then be permanently updated with new data. The 
representative set is expected to include all the main potential variability factors, such as the cancer 
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3.2. Exploratory Analysis of Sensor Data 
As can be seen from Figure 8, two prototypes of the sensor (Section 2.2; Series A and B) yielded 
rather similar data. Figure 8c,d shows mean signals with the same shape, resembling those of the full-
size NIR spectra, with a strong water absorption minimum at 1.44 µm. The channel U1 (1.30 µm) 
shows a particularly high variance. As a result of the different geometry of measurements (Section 
2.3), Series B data generally have a lower intensity. 
Figure 7. Partial least-squares discriminant analysis (PLS-DA) score plots: (a) simulated sensor data of
Series A, and (b) sensor measurements of Series A. Tumor and normal tissue measurements are shown
with red and green markers, respectively. The numbers designate patient IDs.
The analysis of the NIR spectroscopic data presented here was performed for the primary purpose
of sensor development. Full-spectrum measurements enabled the simulation of a four-channel sensor
with theoretically chosen LEDs before its physical construction. The present discrimination modeling
on the basis of poor experimental data including only a few patients was exploratory, but its results
provide the necessary motivation for further sensor development. The practicable diagnostic model
should be built at a later stage of the method development, using a large representative set of patients,
and should then be permanently updated with new data. The representative set is expected to include
all the main potential variability factors, such as the cancer type, grade and staging; and the age, gender,
life-style, presence of others kidney diseases, and other patient-related factors. Clearly, the construction
of such a model requires further extensive dedicated work, which is beyond the scope of this report.
3.2. Exploratory Analysis of Sensor Data
As can be seen from Figure 8, two prototypes of the sensor (Section 2.2; Series A and B) yielded
rather similar data. Figure 8c,d shows mean signals with the same shape, resembling those of the
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full-size NIR spectra, with a strong water absorption minimum at 1.44 µm. The channel U1 (1.30 µm)
shows a particularly high variance. As a result of the different geometry of measurements (Section 2.3),
Series B data generally have a lower intensity.
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wavelength depends on the optical properties of the tissue. These properties are strongly related to 
the size distribution of the cells and organelles responsible for the differentiation between the normal 
and abnormal tissue. Significant biochemical and morphological modification of the tumor-affected 
tissue (Figure 1) seems to be the major reason for its higher scattering coefficient [40]. 
A higher homogeneity of healthy kidney tissues results in a much lower sensor signal variance 
for corresponding samples. A rich lipid content in RCCs yields a characteristic golden-yellow 
appearance of the samples. A varying degree of cystic degeneration, blood particles, calcification and 
necrosis [41] leads to inhomogeneous cut surface (e.g., Figure 2). The possibility of distinguishing 
between normal and tumor tissue samples is essentially based on the backscattered light intensity. 
This is confirmed by the fact that the application of any filtering procedure intended for scatter 
correction (e.g., standard normal variate (SNV)) seriously deteriorates the discrimination power of 
the mathematical model. This was observed when using one of the channels as an internal reference. 
Thus, the data sets for Series A and B were analyzed in a multivariate mode without any scatter-
correcting preprocessing. 
The PLS-DA score plot (Figure 7) is a convenient way to visualize the “strength” of the cancer 
discrimination. In Series A, the tumor/normal class separation in the plane of the two first LVs is 
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were related to the spectral similarity of two different samples from patient 194. This could be 
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Figure 8. Sensor data: (a) Series A, (b) Series B, and (c,d) the data mean and standard deviation in
Series A and B, respectively. Tumor and normal tissue measurements are shown with red and green
lines, respectively. (Reproduced with permission from authors [29]).
The averaged signals in Figure 8c,d imply that tumor tissues had generally higher values of
detected signal intensity for all LEDs as a result of a greater light scattering, which is in a good
agreement with the NIR spectra (Section 3.1). When compared with normal cells, cancer cells are
known to have an increased DNA content, larger nuclear-cytoplasmic ratios and asymmetrical nuclear
shapes. These differences are reflected in the NIR spectra because of the altering interaction of cells
with the radiation; cCRCC tumor cells are typically arranged in compact alveolar, or acinar structures,
such as nests, sheets, etc., and they have a clear cytoplasm. The diameter of cancer cell nuclei can reach
20 µm, while it is around 5–10 µm for normal cells. In these circumstances, the most efficient light
scatterers are generally cell nuclei [39]. The backscattered light intensity at the chosen wavelength
depends on the optical properties of the tissue. These properties are strongly related to the size
distribution of the cells and organelles responsible for the differentiation between the normal and
abnormal tissue. Significant biochemical and morphological modification of the tumor-affected tissue
(Figure 1) seems to be the major reason for its higher scattering coefficient [40].
A higher homogeneity of healthy kidney tissues results in a much lower sensor signal variance for
corresponding samples. A rich lipid content in RCCs yields a characteristic golden-yellow appearance
of the samples. A varying degree of cystic degeneration, blood particles, calcification and necrosis [41]
leads to inhomogeneous cut surface (e.g., Figure 2). The possibility of distinguishing between normal
and tumor tissue samples is essentially based on the backscattered light intensity. This is confirmed by
the fact that the application of any filtering procedure intended for scatter correction (e.g., standard
normal variate (SNV)) seriously deteriorates the discrimination power of the mathematical model.
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This was observed when using one of the channels as an internal reference. Thus, the data sets for
Series A and B were analyzed in a multivariate mode without any scatter-correcting preprocessing.
The PLS-DA score plot (Figure 7) is a convenient way to visualize the “strength” of the cancer
discrimination. In Series A, the tumor/normal class separation in the plane of the two first LVs is almost
complete (Figure 7b). A few measurement points showing discrimination ambiguity problems were
related to the spectral similarity of two different samples from patient 194. This could be explained by
the high content of fat in both the tumor and normal samples of this patient. The bright golden-yellow
color of the tumor sample T194 was clearly due to intracellular lipid accumulation, while the normal
sample N194 might have been a cut of the adipose capsule of the kidney (or perinephric fat), which is
a structure between the renal fascia and the renal capsule. In spite of a reasonably strong variance in
the measurements of tumor samples observed in the factor space of the PLS-DA models, the overall
tendency looks very promising. While none of the individual channels in Figure 8 can allow for
a reliable discrimination of the samples, multivariate data processing yielded rather convincing results.
The class separation was less successful for the Series B data. Prior to the PLS-DA modeling,
the data’s internal structure was investigated by PCA in order to detect outliers and non-typical
measurements. Optical properties of certain individual samples resulted in some discrimination
problems. For example, sample T151 yielded a very compact cluster of points at the left side of LV1,
while the tumor was mainly associated with the positive LV direction. Figure 2a shows that these two
particular samples from patient 151 had very different visual appearances. The investigation of some
specific locations on the samples revealed further inconsistencies. Thus, the PCA score plot (Figure 9)
shows that all Cn measurements of T144 exhibited similar trends to the tumor sample T151 (located
in the healthy group), although other measuring locations of T144 appeared in the red zone. On the
other hand, Cn measurements of N144 (normal sample of this patient) were false positive outliers.
The PLS-DA modeling statistics (Table 1) could be improved significantly by the elimination of the
only sample T151 and two measurement positions N144_Cn and T144_Cn (about 18% of the data).
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3.3. PLS-DA of Sensor Data and Model Validation 
Unlike PCA, the PLS-DA is a supervised classification method using the factor space optimized 
for a particular discrimination task. The calibration and validation statistics of PLS-DA models for 
Series B are given in Table 1. No large discrepancy between the calibration and different validation 
statistics is observed. As expected, the full CV was generally more optimistic, but changing the 
validation method to segmented CV did not result in any dramatic consequences for the models. The 
segmented CV with the segments formed by measurement positions in Series B was the most 
straightforward CV strategy in the present research. Repeated measurements in the same sample 
position produced similar spectra or sensor data; therefore, these should always be simultaneously 
excluded for every CV iteration. The sample-based segmented CV was perhaps too crude because of 
Figure 9. Score plot of the first two latent variables (LV2 vs LV1) for a principal component analysis
(PCA) model for the sensor data of Series B: (a) full area, and (b) magnification of selected area in (a).
Tumor and normal tissue measurements are shown with red and green markers, respectively. The
numbers designate patient IDs.
3.3. PLS-DA of Sensor Data and Model Validation
Unlike PCA, the PLS-DA is a supervised classification method using the factor space optimized for
a particular discrimination task. The calibration and validation statistics of PLS-DA models for Series B
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are given in Table 1. No large discrepancy between the calibration and different validation statistics
is observed. As expected, the full CV was generally more optimistic, but changing the validation
method to segmented CV did not result in any dramatic consequences for the models. The segmented
CV with the segments formed by measurement positions in Series B was the most straightforward
CV strategy in the present research. Repeated measurements in the same sample position produced
similar spectra or sensor data; therefore, these should always be simultaneously excluded for every
CV iteration. The sample-based segmented CV was perhaps too crude because of a high risk of model
bias, when one of three available tumor or normal samples was eliminated from the training dataset.
RSV is another viable option to validate multivariate models built on relatively small datasets.
The subset volume of 15% was a reasonable trade-off between the representativeness of the residual
training set and the statistical reliability of the prediction. It has been verified that varying the
subset size between 10% and 20% does not affect the modeling statistics significantly. RSV combines
the advantages of independent validation (although it is not strictly independent because of the
repeat-and-average approach) with efficient data use, as in CV. RSV statistics take an intermediate
position between the LOO and segmented CV approaches. It is remarkable that for the most
representative refined sensor model, Bs140, the RSV metrics were virtually the same as for LOO
CV (Table 1).
The models for the sensor data As33 and Bs140 successfully passed PTs (Section 2.5). A large
difference between the NMC statistics for the original and any randomized order of the samples in the
y-vector of responses (Figure 10) additionally confirmed the predictive capabilities of the respective
PLS-DA models. A high efficiency of the y-permutation test to protect against chance correlation has
been illustrated in [42].
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Validation with a random 15% subset at 1000 iterations was used; sorted mean number of 
misclassified measurements (NMC) metrics are presented. Blue bar at zero permutation number 
corresponds to original non-permuted data. 
The evident consistency of different validation and calibration statistics presented in Table 1 as 
well as the PT results provide convincing proof that our preliminary discrimination models reflect 
the real sensor capabilities of tumor diagnostics. The moderate complexity of the models (two LVs) 
is further evidence against any significant overfitting. 
A thorough validation, including full, segmented and random-subset CVs, as well as 
randomization tests, are recommended in any cases for which important conclusions depend on 
calibration or discrimination models built on limited experimental material. 
As a general conclusion from the experimental analysis of the kidney samples, it can be stated 
that the LED-based sensing approach developed in the present work is capable of discriminating 
between tumor and healthy tissues. Taking into account the data diversity in Series B, it can be taken 
as a reasonably good first estimate of the real-life applicability of the sensor. The technical quality of 
the method is additionally confirmed by a good reproducibility of the measurements in individual 
samples and in particular sample sites. 
Figure 10. Permutation tests of partial least-squares discriminant analysis (PLS-DA) models for sensor
measurements: (a) Series A, and (b) refined Series B (As33 and Bs140 models in Table 1, respectively).
Validation with a random 15% subset at 1000 iterations was used; sorted mean number of misclassified
measurements (NMC) metrics are presented. Blue bar at zero permutation number corresponds to
original non-permuted data.
The evident consi tency of different validation and calibrat on statistics prese ted in Table 1 as
well as the PT results provide convincing pr of that our preliminary discrimination models reflect the
real sensor capabilities of tumor diagnostics. The moderate complexity of the models (two LVs) is
further evidence against any significant overfitting.
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A thorough validation, including full, segmented and random-subset CVs, as well as
randomization tests, are recommended in any cases for which important conclusions depend on
calibration or discrimination models built on limited experimental material.
As a general conclusion from the experimental analysis of the kidney samples, it can be stated
that the LED-based sensing approach developed in the present work is capable of discriminating
between tumor and healthy tissues. Taking into account the data diversity in Series B, it can be taken
as a reasonably good first estimate of the real-life applicability of the sensor. The technical quality of
the method is additionally confirmed by a good reproducibility of the measurements in individual
samples and in particular sample sites.
4. Discussion and Conclusions
LED-based optical sensor technology has already been shown to be suitable for the production
of miniaturized chemical sensors and optical diagnostic devices (e.g., pulse oximetry and detection
of oral cancer [43]). The presented combination of LEDs with simple photodiode detection provides
a good alternative to full-sized spectroscopic devices and allows for a fine tuning of the analysis
to the requirements of a particular practical task. Another method advantage is the possibility
of miniaturization, which is especially important in the context of real-time medical diagnostics.
Distinguishing between tumor and non-tumor tissues using LED-based sensors is a new approach,
and much work remains to be done. A significant technical simplification of the LED-based sensing,
compared to the conventional full-range spectroscopy, should result in a dramatic reduction of the
device’s purchase and maintenance prices. Additionally, LED sensors are portable and do not require
the permanent availability of a computer and power supply. The appearance of a budget tool for
cancer diagnostics, and hence, the growing total number of analyses are expected to have a positive
impact on human health worldwide. The choice between a spectrometer and an LED-based sensor
does not necessarily indicate a trade-off between the analysis price and reliability. Using a limited
number of wavelengths rather than the full spectrum makes it easier to focus on the most informative
signals, therefore avoiding the areas of noise and irrelevant variance. This concept is particularly
useful for the investigation of complex biological objects.
This study provides a proof-of-concept demonstration of the LED-based sensor for tumor
discrimination. Only four LEDs with emission wavelengths in the NIR range were employed.
Further dedicated studies are needed to yield the next sensor prototype. For example, examinations of
various organs, the selection of optimal wavelengths, and data processing methods must be addressed.
The presented technology of diffuse reflectance NIR sensing for tumor diagnostics can be extended to
other tissue and cancer types. To provide the optimal sensor performance, the working LED set, that is,
the LED number and wavelengths, should be adapted to each case individually to take respective
biomarkers and optical properties of the tissue into account. The experimental and data analysis
approaches suggested here can be used to minimize the number of clinical measurements during the
development stage.
The main disadvantage of the LED-based sensor in its present form is a very high measurement
variance in cancer tissue samples (Figure 9). The main requirement for the sensor improvement is
therefore to increase the accuracy and specificity of detection, as FN are unacceptable outcomes in
oncological diagnostics. Although the sensor performance demonstrated by the present prototype
should be further improved, the results reported here can be considered as a successful feasibility
study of an LED-based NIR sensor for cancer diagnostics aimed at in vivo applications. The sensor’s
general sensitivity to the kidney tumors, illustrated here, provides the necessary motivation for further
development of the method.
The directions for the further improvement of the sensor are (1) LED number and wavelength
optimization, (2) optimization of the measurement conditions (distance, angle, light intensity, spectral
reference, probe construction, elimination of environmental effects, etc.), and (3) data processing
optimization. These improvements represent an important part of the future work.
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